In this analysis, as well as clinical stage, recurrence and metastasis, CHD1L expression (hazard ratio, 7.916; 95% confidence level, 2.067–16.034; P=0.003) was an independent prognostic factor for patients with NPC (Table III). This evidence concerns the gene CHD1L and nasopharyngeal carcinoma.